SAN DIEGO – September 4, 2022 – (Newswire.com)

OTS is pleased to announce that after two years of virtual meetings, the 18th Annual Oligo Meeting will feature a robust in-person program live from the Hilton Phoenix Resort at the Peak in Phoenix, Arizona, where delegates from many different countries will be able to participate in lively discussions and once again engage face-to-face. This year’s gathering, taking place October 2-5, is a hybrid event and will also include a virtual component, allowing delegates unable to attend in person to enjoy the annual gathering from the comfort of their own homes or offices .

The Oligonucleotide Therapeutics Society (OTS) is an open, non-profit forum promoting academic and industry-based research and development of oligonucleotide therapeutics. The vision of the founders was to bring together expertise from different angles of oligonucleotide research to create synergies and push the field of oligonucleotides to its full therapeutic potential.

The OTS Annual Meeting is a forum for the realization of the Society’s mission and goals. At the annual meeting, anyone interested or involved in oligonucleotide therapeutics can attend and benefit from the incredible opportunity to learn from and engage with experts, post-docs and undergraduate students to facilitate interdisciplinary exchange and the Develop breakthrough innovations to encourage new ideas.

Due to the efforts and persistence of professionals in this field, several oligonucleotide therapeutic treatments have been approved by regulatory bodies around the world, two mRNA Covid-19 vaccines have been developed due to decades of previous development in this field and over 100 oligonucleotide therapeutic treatments are located under development for common diseases, including cancer and Alzheimer’s, as well as for rare diseases. Incredibly, oligonucleotide therapeutics are being used to develop individualized treatments for people with extremely rare, deadly diseases.

Participants of this year’s…